Core and Group Health

Forty-three percent of reviewed hospitals are posting fewer prices now than in the November 2024 report.

"This is more than just policy talk -- it's the kind of change that could disrupt the entire health care ecosystem," said Eric Crites, senior vice president of enterprise partnerships at Q-Centrix.

DPC relationships can save money and improve patient satisfaction, but overseeing the care takes work.

Their problems with collections could give employers room to negotiate.

Anthem Blue's parent maintains in the complaint that underwriting expertise is crucial to its competitive edge.

Employer costs for GLP-1 agonists and similar drugs could end up averaging $3.17 to $22.88 per enrollee per month.